• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bone marrow with gelatinous transformation associated with residual disease in imatinib mesylate-treated chronic myelogenous leukaemia (CML).

作者信息

Thakral Beenu, Higa Bryce, Venkataraman Girish, Velankar Milind M

出版信息

Pathology. 2012 Jan;44(1):59. doi: 10.1097/PAT.0b013e32834e42df.

DOI:10.1097/PAT.0b013e32834e42df
PMID:22157697
Abstract
摘要

相似文献

1
Bone marrow with gelatinous transformation associated with residual disease in imatinib mesylate-treated chronic myelogenous leukaemia (CML).甲磺酸伊马替尼治疗的慢性粒细胞白血病（CML）中，骨髓呈胶样变性并伴有残留病。
Pathology. 2012 Jan;44(1):59. doi: 10.1097/PAT.0b013e32834e42df.
2
Gelatinous transformation of the bone marrow as a late morphological change in imatinib mesylate treated chronic myeloid leukaemia.骨髓的胶样变性作为甲磺酸伊马替尼治疗慢性髓性白血病的晚期形态学改变。
Pathology. 2010 Jan;42(1):84-5. doi: 10.3109/00313020903434686.
3
Gelatinous transformation of bone marrow in chronic myeloid leukemia during treatment with imatinib mesylate: a disease or a drug effect?
Acta Haematol. 2008;119(2):104-7. doi: 10.1159/000121825. Epub 2008 Mar 27.
4
Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status.甲磺酸伊马替尼（格列卫）治疗后的慢性髓性白血病。骨髓组织病理学及其与基因状态的相关性。
Am J Clin Pathol. 2003 Jun;119(6):833-41. doi: 10.1309/A4RG-P4LF-12GG-H8MW.
5
Persistent neutropenia in chronic myelogenous leukemia in chronic phase treated with imatinib mesylate.甲磺酸伊马替尼治疗慢性期慢性粒细胞白血病时的持续性中性粒细胞减少症。
Am J Hematol. 2009 May;84(5):302-5. doi: 10.1002/ajh.21383.
6
[Monitoring bcr/abl mRNA levels in imatinib mesylate treated chronic myeloid leukemia patients by real-time quantitative RT-PCR].[采用实时定量逆转录聚合酶链反应监测甲磺酸伊马替尼治疗的慢性髓性白血病患者的bcr/abl mRNA水平]
Zhonghua Xue Ye Xue Za Zhi. 2005 Jan;26(1):1-5.
7
Cytogenetic and fluorescence in situ hybridization monitoring in Ph+ Chronic Myeloid Leukemia patients treated with imatinib mesylate.接受甲磺酸伊马替尼治疗的Ph+慢性髓性白血病患者的细胞遗传学和荧光原位杂交监测
J Exp Clin Cancer Res. 2004 Jun;23(2):295-9.
8
Questioning the aim of CML therapy in the era of Imatinib?在伊马替尼时代，对慢性粒细胞白血病治疗目标提出质疑？
Leukemia. 2003 Jun;17(6):1199-200. doi: 10.1038/sj.leu.2402954.
9
Imatinib mesylate therapy reduces bone marrow fibrosis in patients with chronic myelogenous leukemia.甲磺酸伊马替尼治疗可减轻慢性粒细胞白血病患者的骨髓纤维化。
Cancer. 2004 Jul 15;101(2):332-6. doi: 10.1002/cncr.20380.
10
Achievement of complete molecular responses in late chronic phase chronic myeloid leukaemia patients treated with pulsed imatinib while in minimal residual disease.
Leuk Res. 2009 May;33(5):645-8. doi: 10.1016/j.leukres.2008.10.024. Epub 2008 Dec 4.

引用本文的文献

1
Gelatinous Transformation of Bone Marrow Following Lymphoma and a Novel, Potential Treatment.淋巴瘤后骨髓的胶样变性及一种新型潜在治疗方法
Cureus. 2024 Apr 30;16(4):e59354. doi: 10.7759/cureus.59354. eCollection 2024 Apr.
2
Gelatinous transformation of bone marrow: rare or underdiagnosed?骨髓的胶样变性：罕见还是诊断不足？
Autops Case Rep. 2017 Dec 8;7(4):8-17. doi: 10.4322/acr.2017.039. eCollection 2017 Oct-Dec.
3
Gelatinous Marrow Transformation Associated with Imatinib: Case Report and Literature Review.与伊马替尼相关的胶冻样骨髓转化：病例报告及文献综述
Case Rep Hematol. 2017;2017:1950724. doi: 10.1155/2017/1950724. Epub 2017 Jan 4.
4
Gelatinous Marrow Transformation in an Imatinib-Treated CML Patient with Pancytopenia Following Severe Sepsis.伊马替尼治疗的慢性粒细胞白血病患者在严重脓毒症后出现全血细胞减少伴胶冻样骨髓转化
Indian J Hematol Blood Transfus. 2014 Mar;30(1):72-4. doi: 10.1007/s12288-012-0188-1. Epub 2012 Aug 23.
5
Gelatinous transformation of bone marrow following the use of dasatinib in a patient with philadelphia chromosome-positive acute lymphoblastic leukemia.在一名费城染色体阳性急性淋巴细胞白血病患者中使用达沙替尼后出现的骨髓胶样变性。
Leuk Res Rep. 2013 Jan 7;2(1):7-8. doi: 10.1016/j.lrr.2012.11.004. eCollection 2013.